Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1 × Propranolol × Thoracic × Clear all

Phase

Phase 2 1 Phase 1 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1 Sarcoma 1 Gynecologic 1 Dermatologic 1

Conditions

Carcinoma, Non-Small-Cell Lung 1

Interventions

pembrolizumab 127 Carboplatin 120 Cisplatin 115 Pemetrexed 89 Paclitaxel 70 Nivolumab 59 Radiotherapy 58 Docetaxel 56 Erlotinib Hydrochloride 54 Gemcitabine 49 osimertinib 37 durvalumab 37 Etoposide 37 Bevacizumab 37 Cyclophosphamide 36 atezolizumab 31 Cetuximab 29 Radiosurgery 22 130-nm albumin-bound paclitaxel 20 fludarabine 19 Magnetic Resonance Spectroscopy 19 Irinotecan 19 Vinorelbine 17 Specimen Handling 17 Gefitinib 17 Fluorouracil 17 Everolimus 17 Topotecan 16 Radiation 16 Oxaliplatin 16

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05979818 2024-11-19

BRIO

Second Xiangya Hospital of Central South University

Phase 1 Recruiting

Carcinoma, Non-Small-Cell Lung

Data powered by HemOnc (CC BY 4.0) Colophon ⚡